Loading clinical trials...
Loading clinical trials...
Women who meet the study requirements will be enrolled and randomly assigned by a computer system to receive either pioglitazone 30 mg daily or a placebo starting from the second day of their menstrua...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
PAEC General Hospital, Islamabad
NCT07185724 · Infertility (IVF Patients), Infertility Treatment, and more
NCT07289269 · Infertility Treatment
NCT06838923 · Embryo Development, Blastocyst IVF, and more
NCT01809366 · Effect on Implantation and Pregnancy Rates
Pakistan Atomic Energy Commission Hospital
Islamabad, Federal
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions